NCT00856323View on ClinicalTrials.gov

Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Amphetamine-Related DisordersHIVHIV Infections
Interventions
DRUG

Truvada

At qualifying exposure, participants will take 28 days' worth (at one pill per day) of 200 mg emtricitabine and 300 mg tenofovir DF (Truvada).

BEHAVIORAL

CM

Participants will submit a urine sample every Monday, Wednesday, and Friday for 8 weeks (a total of 24 urine samples). Samples will be tested for methamphetamine metabolites.

Trial Locations (1)

90028

Friends Community Center, Los Angeles

Sponsors
All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

Friends Research Institute, Inc.

OTHER